NDC 80425-0199-01 - Gabapentin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0199
- Requested NDC
- 80425-0199-01
- Package NDCs from labels
- 80425-0199-2, 80425-0199-3, 80425-0199-1, 80425-0199-4, 80425-0199-01
- Manufacturer
- Advanced Rx Pharmacy of Tennessee, LLC
- Effective date
- 2024-12-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Gabapentin - Advanced Rx Pharmacy of Tennessee, LLC | Advanced Rx Pharmacy of Tennessee, LLC | 2024-12-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0199-1 | Gabapentin | 30 in 1 BOTTLE | CAPSULE | 30 | 5 | |
| 80425-0199-2 | Gabapentin | 60 in 1 BOTTLE | CAPSULE | 60 | 5 | |
| 80425-0199-3 | Gabapentin | 90 in 1 BOTTLE | CAPSULE | 90 | 5 | |
| 80425-0199-4 | Gabapentin | 120 in 1 BOTTLE | CAPSULE | 120 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0199 | GABAPENTIN CAPSULE [ADVANCED RX PHARMACY OF TENNESSEE, LLC] | 5 | Current NDC, Legacy NDC, 4 package rows | 20250101_ec1c621b-db2a-1567-e053-2995a90a8695.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0199-1 | EA - Each | 80425-0199 | d68dc437-0849-41c2-b17b-257d12f6b61c | 1 | 2023-06-06 |
| 80425-0199-2 | EA - Each | 80425-0199 | 72852c7a-f605-4712-bd72-41cd7fab8078 | 1 | 2023-06-06 |
| 80425-0199-3 | EA - Each | 80425-0199 | d088f4ae-c84a-47de-954a-d5659921b2bf | 1 | 2023-06-06 |
| 80425-0199-4 | EA - Each | 80425-0199 | 23d7cfee-4b7b-41a1-a066-247e8cdd763e | 1 | 2023-06-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| GABAPENTIN | GABAPENTIN | NuCare Pharmaceuticals,Inc. | febf610e-e088-4797-e053-6294a90a3eb5 | 2025-02-04 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | NuCare Pharmaceuticals,Inc. | 07871ab8-254b-e3c2-e063-6294a90a29ab | 2025-02-03 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | NuCare Pharmaceuticals,Inc. | 0919fed8-e968-b5ac-e063-6294a90afbff | 2025-02-03 | Warnings, Adverse reactions | ANDA075477 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | a1ff94a9-69c4-486a-aab2-563c7ed244c8 | 2025-01-30 | Warnings, Adverse reactions | 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Coupler LLC | 2cdbb381-88a2-5c5a-e063-6294a90a3e1e | 2025-01-29 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | NuCare Pharmaceuticals, Inc. | 2c65253d-ca49-70eb-e063-6394a90a3cd2 | 2025-01-23 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Direct_Rx | e90d2e3d-ec86-7d1d-e053-2995a90a9167 | 2025-01-22 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Direct_Rx | ed9cb5fe-7a2e-e0bc-e053-2a95a90a4470 | 2025-01-22 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Direct_Rx | f40a4ee4-ae8e-769c-e053-2a95a90a344e | 2025-01-22 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Directrx | d5c9dd2c-b8ee-1406-e053-2995a90a0287 | 2025-01-21 | Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Preferred Pharmaceuticals Inc. | db57e37f-0a78-4c14-8768-a28bbf9fa0da | 2025-01-21 | Warnings, Adverse reactions | 310432 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | DIRECT RX | a5b47f89-ed35-31de-e053-2a95a90a5554 | 2025-01-17 | Warnings, Adverse reactions | 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | DIRECT RX | a7e45e3f-e382-32ba-e053-2a95a90a2537 | 2025-01-17 | 310430 310432 6CW7F3G59X | |
| Gabapentin | GABAPENTIN | Clinical Solutions Wholesale, LLC | 743faa18-5e7c-4fcc-9781-4157450d90c4 | 2025-01-16 | Warnings, Adverse reactions | 310432 6CW7F3G59X |
| Gabapentin | GABAPENTIN | NuCare Pharmaceuticals,Inc. | bd5c9279-a1e3-2a59-e053-2a95a90a33a2 | 2025-01-14 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Aphena Pharma Solutions - Tennessee, LLC | 41ce952c-6c16-4b5d-adf7-9ea114e63eb3 | 2025-01-09 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Aphena Pharma Solutions - Tennessee, LLC | 13b87441-8fe1-40f5-8ffb-00dcd8cc90a6 | 2025-01-09 | Warnings, Adverse reactions | 310432 6CW7F3G59X |
| Gabapentin | GABAPENTIN | AvPAK | faa47fcd-2545-a946-e053-6294a90a05d2 | 2025-01-09 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Aphena Pharma Solutions - Tennessee, LLC | 95757436-2093-41cf-a9a9-ef2f28ac096f | 2025-01-09 | Warnings, Adverse reactions | 310432 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | NuCare Pharmaceuticals,Inc. | 2b395a14-0f8e-7f5b-e063-6294a90ab546 | 2025-01-08 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.